Standard BioTools Inc. (NASDAQ: LAB), a key player in the healthcare sector specializing in medical devices, presents a compelling investment opportunity with its potential for a 61.80% upside, according to..
AtaiBeckley Inc. (NASDAQ: ATAI), a clinical-stage biopharmaceutical company focused on innovative treatments for mental health disorders, is capturing significant attention from investors and analysts alike. Operating primarily in the United..
Cross Country Healthcare, Inc. (NASDAQ: CCRN) stands out as a key player in the healthcare sector, specifically within the medical care facilities industry. With a market capitalization of $318.75 million,..
Celcuity Inc. (NASDAQ: CELC), a clinical-stage biotechnology company, is turning heads in the healthcare sector with its innovative approach to cancer treatment. Based in Minneapolis, Minnesota, Celcuity focuses on developing..
Tilray Brands, Inc. (NASDAQ: TLRY), a prominent name in the healthcare sector under the specialty and generic drug manufacturers industry, presents an intriguing opportunity for investors willing to navigate the..
SIGA Technologies Inc. (NASDAQ: SIGA), a company at the forefront of the health security market with its leading antiviral product TPOXX, presents a mixed bag for investors. The New York-based..
AngioDynamics, Inc. (NASDAQ: ANGO), a leader in the healthcare sector specializing in medical instruments and supplies, is catching the attention of investors with a noteworthy potential upside of 71.55%, according..
Tectonic Therapeutic, Inc. (NASDAQ: TECX) is capturing the attention of investors with its promising biotechnology innovations and an impressive potential upside of 154.39% according to analyst ratings. With its core..
Sana Biotechnology, Inc. (NASDAQ: SANA) presents an intriguing opportunity for investors looking to tap into the burgeoning field of engineered cell therapies. Operating in the healthcare sector, specifically within the..
Oric Pharmaceuticals, Inc. (NASDAQ: ORIC), a dynamic player in the biotech sector, is capturing the attention of investors with its promising therapeutic developments aimed at countering cancer resistance mechanisms. With..
